CATS has been the subject of several other reports. Zacks Investment Research raised Catasys from a sell rating to a hold rating in a report on Tuesday, August 21st. Canaccord Genuity increased their price objective on Catasys from $12.00 to $15.00 and gave the company a buy rating in a report on Wednesday, September 26th. Finally, ValuEngine raised Catasys from a buy rating to a strong-buy rating in a report on Tuesday, October 2nd.
Shares of Catasys stock opened at $11.71 on Thursday. The company has a market capitalization of $177.50 million, a price-to-earnings ratio of -13.78 and a beta of 1.16. Catasys has a 52 week low of $3.30 and a 52 week high of $14.29.
Several hedge funds have recently bought and sold shares of CATS. Uniplan Investment Counsel Inc. acquired a new stake in shares of Catasys in the third quarter valued at approximately $3,511,000. Janney Montgomery Scott LLC boosted its holdings in shares of Catasys by 340.0% in the second quarter. Janney Montgomery Scott LLC now owns 162,515 shares of the company’s stock valued at $1,092,000 after acquiring an additional 125,577 shares during the period. EAM Investors LLC acquired a new stake in shares of Catasys in the second quarter valued at approximately $679,000. Essex Investment Management Co. LLC acquired a new stake in shares of Catasys in the third quarter valued at approximately $1,255,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Catasys by 53.8% in the third quarter. Vanguard Group Inc. now owns 171,813 shares of the company’s stock valued at $2,208,000 after acquiring an additional 60,090 shares during the period. 9.13% of the stock is owned by institutional investors and hedge funds.
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Featured Story: Compound Interest
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.